EPTRI

Funding programme: Horizon 2020 (N 654248)

Coordinator: CONSORZIO PER VALUTAZIONI BIOLOGICHE E FARMACOLOGICHE (CVBF)

Budget: €3M

Duration: 24 months (January 2018 to April 2020)

European Paediatric Translational Research Infrastructure (EPTRI) is a project that arises from the need to find answers to the serious lack of medicines for children in EU and worldwide. It aims to propose developmental models for a future research infrastructure focused on paediatric medicines, integrating technology-driven aspects with clinical trials.

The project ID-EPTRI, coordinated by Consorzio per Valutazioni Biologiche e Farmacologiche (CVBF) and funded within the H2020-INFRADEV-01-2017 programme, aims to design the framework for the new RI providing a conceptual design report (CDR) of EPTRI describing the scientific and technical requirements as well as the key components of the new RI. Five technical and scientific domains have been identified:

• Paediatric Medicines Discovery
• Biomarkers
• Paediatric Pharmacology
• Formulation Science
• Underpinning Paediatric Studies

To harness efficiency in delivery of paediatric research activities and services, EPTRI plans to act as a “paediatric common service” with three already established Research Infrastructures (BBMRI, EATRIS, ECRIN).